Precision BioSciences (DTIL) Reports Q1 Loss, Lags Revenue Estimates

Precision BioSciences (DTIL) came out with a quarterly loss of $2.21 per share versus the Zacks Consensus Estimate of a loss of$ 0.43. This compares to loss of $0.35 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -413.95%. A quarter ago, it was expected that this genome editing company would post a loss of$ 0.42 per share when it actually produced a loss of $3.20, delivering a surprise of -661.90%.Over the last four quarters, ...